such as prostaglandins, thromboxanes, and 15hydroxyeicosatetraenoic acids (HETEs) are collectively referred to as eicosanoids. These products are known to be involved in such processes as inflammation, ovulation, modulation of immune responses, and mitogenesis. To understand the role of arachidonic acid metabolites in these processes it is important to understand which downstream signaling pathways are affected. The regulation of eicosanoid production has become an area of intense study because these fatty acid metabolites affect multiple signaling pathways that modulate a wide range of physiological functions.
There are multiple steps in the biosynthetic pathway for eicosanoids that are possible sites of regulation (Fig.  1) . The first step is the liberation of arachidonic acid from membrane phospholipid by phospholipase. Several phospholipases have been characterized, including cardiac phospholipase A2 (PLAg) and secretory PLAZ. Of interest, one of the phospholipase genes was recently shown to act as a modifier (Moml) in multiple intestinal neoplasia (Min) mice. Min mice have a mutated gene [adenomatous polyposis coli (AK')], which leads to the development of multiple intestinal tumors (67). The gene for secretory PLAB was recently reported as one of the modifier genes that alters the number of intestinal tumors when affected (39). Phospholipases were thought to be the most important regulatory step in prostaglandin production.
Following liberation from phospholipid, free arachidonic acid is converted to prostaglandin G/II2 (PGH2), the upstream metabolite for prostaglandins and thromboxanes via prostaglandin G/H synthase-1 (PGHS-1) (8,11,14-eicosatrienoate, hydrogen donor: oxygen oxidoreductase, EC 1.14.99.1), which is referred to as cyclooxygenase-1 (COX-1) in this review (Fig. 1 ). This enzyme was purified from bovine vesicular glands by Miyamoto et al. (43) in 1976. COX-1 mRNAand protein are present at relatively stable levels in many tissues, but prostanoid production in these tissues is variable. Therefore, it was originally thought that conversion of arachidonate to PGHs was not a likely regulatory step, and that regulation occurred either at arachidonate release or at some distal step in the metabolic pathway.
In 1989 Simmons et al. (62) identified a second, inducible form of cyclooxygenase, known as prostaglandin endoperoxide synthase-2 (COX-2). This cyclooxygenase isoform was independently identified by differential screening of a phorbol ester-stimulated Swiss-3T3 fibroblast cDNA library (33) and subsequently by many other groups. COX-2 expression is inducible by a wide range of extracellular and intracellular stimuli, including lipopolysaccharide (15,37,51), forskolin (34), interleukin-1 (IL-l), tumor necrosis factor (TNF) (7, 16, 27 serum (8, 58) , epidermal growth factor (EGF) (ZZ), synaptic activity (74), transforming growth factor-a (TGF-ar) (ll), human chorionic gonadotropin (63), interferon-y (56), platelet activating factor, retinoic acid (3), and endothelin (29). Additionally, the formation of COX-2 protein parallels the increase in prostanoid production that is commonly the result of mitogenic stimulation in a wide variety of cell types, Prostaglandin production increases rapidly in rat intestinal epithelial cells (RIE) after stimulation with mitogens such as TGF-cu or EGF (11). Under resting conditions, these cells have undetectable COX-2 levels; hence prostaglandins are not being produced by this enzyme. The regulation of COX-2 expression is a key step in prostanoid production in rat intestinal epithelial cells.
If one assumes that these two enzymes have similar other induced? Though COX-1 and COX-2 produce similar products, it seems likely that there is some reason for the existence of these two distinct, but related, enzymes. One possibility is that these two isoforms provide different roles because they are located in separate subcellular compartments (45). Determining the biological role each isoform plays in the organism is an important question that is currently under intense study.
STRUCTURE
The genomic structure of both human (75) and murine (32) COX-1 is composed of 11 exons and 10 introns spanning 22.5 kb. The human COX-1 locus maps to chromosome 9q32-q33.3. By comparison, the human COX-2 gene is only 8.3 kb in size. This reduction or identical activities, then one obvious question to ask in size is primarily due to smaller introns. Most of the is, Why are there two isoforms? Why is one isoform exons are conserved, with the exception of the absence constitutively expressed in most cell types, and the of exon 2 in COX-2 ( hybridization localized human COX-2 to chromosome lq25. 2-q25.3 (31) . It is of interest to note that one of the phospholipase genes (PLA2 G4) is in extremely close proximity to the COX-2 gene on chromosome 1, located at lq24-q25. Because secretory PLA2 has been reported as one of the modifier genes of the Min phenotype, the close proximity of COX-2 and PLAB could have some biological relevance (39).
This region is extremely AT rich and contains 17 copies of the Shaw-Kamens sequence (ATTA) (5, 60). This motif is present in many immediate early genes and is thought to be involved in modulating the rate of mRNA degradation (3 1). Interestingly, these sequences are conserved between murine and human COX-2 genes, suggesting an important role for their presence.
Homology comparisons of the 5'-flanking regions of the two cyclooxygenase genes reveals little similarity. However, the COX-2 promoter region is partially conserved between species (63%). The human and chicken COX-2 promoters contain a canonical TATA box, whereas the murine and rat promoters do not possess such a sequence. Computerized motif searches suggest that the following transcription factor consensus sequences are present in the COX-2 promoter: CArG box, NF-IL-6
(nuclear factor of IL-6), murine nuclear protein-l (PEA-l), myb, GATA-1, xenobiotic response element, adenosine 3',5'-cyclic monophosphate (CAMP) response element, NF-KB, PEA-3, and substance Pl. Additionally, there is a 12-0-tetradecanoylphorbol-13-acetate (TPA) response element buried in exon 1 (31). Gel-shift assays and analysis of promoter deletion constructs have revealed that the CAAT enhancer binding protein-l3 homology sequence (5 ' TTATGCAAT 3') in the COX-2 promoter is required for transcriptional activation of COX-2 by forskolin, luteinizing hormone, and follicle stimulating hormone (64). It is interesting to note that despite the fact that COX-2 transcription increases with serum addition, the rat COX-2 promoter lacks an identifiable serum response element in the 5'-flanking sequence. Because the COX-2 gene has been shown to be upregulated during inflammation and after cytokine or phorbol ester treatment, it is not surprising that NF-KB, NF-IL-6, CAMP, and TPA response enhancer elements are present. These factors are known to be upregulated during an inflammatory response. The significance of both the myb and xenobiotic response elements is yet to be determined. After mitogenic stimulation, the level of COX-2 mRNA rapidly increases within 30 min in a cycloheximideindependent fashion (8, 27) and remains elevated for 6-8 h before rapidly declining to baseline levels within 24 h (11). Additional stimulation results in no further COX-2 production, providing a classic example of immediate early or primary response gene activation (46).
The transcription of COX-1 and COX-2 yields mRNAs that are 2.7 and 4.5 kb in size, respectively (Fig. 3) . There have been reports of splice variants being produced from the COX-1 primary transcript as a result of TGF+l, IL-1p, TNF-(x, phorbol esters, and serum stimulation (9). There is also some evidence for alternative splicing of the COX-2 mRNA. Xie et al. (73) used chicken embryo fibroblasts that were permanently transfected with temperature-sensitive v-src, a potent COX-2 inducer, to investigate splice variation of the COX-2 mRNA. They observed that in nonproliferating fibroblasts expressing v-src, the predominate COX-2 mRNA possessed an unspliced intron that prohibited translation (73). Upon transformation and mitogenic stimulation, the majority of the COX-2 mRNA produced was of the completely spliced derivative and was translated into COX-2 protein. To our knowledge, additional work characterizing the tissue prevalence of this alternative transcript or the machinery involved in the differential splicing has not been reported.
The 3'-untranslated region of human COX-2 possesses three polyadenylation signals, which may explain why there is some variation in the sizes of transcripts observed on Northern analysis (4.3-4.5 kb).
COX-1 mRNA encodes a 565-residue, 65-kDa protein containing a short signal peptide and four possible N-linked glycosylation sites (Fig. 3) . In Fig. 3 the COX-1 and COX-2 cDNA and protein structures are compared in a linear fashion. COX-2, a roughly 70-kDa protein, is -75% homologous to the COX-1 protein. The cyclooxygenase and peroxidase regions are conserved between the two proteins; however, there are some other differences in the primary amino acid sequence. The amino terminus is slightly truncated in COX-2 compared with COX-1, and the carboxy terminus of COX-2 possesses an l&residue insert that is absent from COX-1. It is possible these subtle differences in the primary amino acid sequence may cause differences in the secondary and tertiary structure of the protein that could affect the active site of these two enzymes. (12) reported that of 14 human colonic carcinomas screened, 12 had increased COX-2 mRNA, and of 14 unpaired adenomas screened, 43% had increased levels of COX-2 mRNA. The decrease in incidence of elevated COX-2 expression in benign adenomas is not surprising, considering that adenomas are precursors to carcinomas and are expected to express a different array of gene products. Indeed, the fact that there is a marked elevation of COX-2 mRNA in the adenomas compared with normal adjacent mucosa may indicate that increased expression of COX-2 is involved in the progression to a transformed state. Therefore, the increased COX-2 levels in adenomas may be useful as a prognostic marker for tumorigenesis in the intestinal epithelium.
Studies from other laboratories have confirmed our findings and shown that COX-2 protein levels are increased in a significant number of colorectal carcinomas as well (28) . However, COX-1 expression was low in both normal mucosa and tumor samples. More extensive patient studies will have to be performed before any definite conclusions can be drawn about the feasibility of utilizing COX-2 levels as a prognostic marker.
MODELING INTESTINAL TUMORIGENESIS
Colonic epithelial cells in vivo express low levels of COX-1 and almost undetectable levels of COX-2, whereas colorectal cancers express 2-to 50-fold higher levels of COX-2. Immunostaining of colorectal cancer tissue sections reveals that the bulk of COX-2 protein is expressed in malignant colonic epithelial cells (59). We sought to set up an in vitro model of this cyclooxygenase expression pattern found in colorectal cancer by engineering rat intestinal epithelial (RIE) cells to overexpresses COX-2 (RIE-sense) constitutively (71). We used normal RIE cells as controls, in addition to a cell line overexpressing the COX-2 cDNA inserted in the antisense orientation.
Appropriate experiments were conducted to confirm that COX-2 was being expressed and was functional in the RIE-sense cell lines, and absent from the antisense RIE cells. Intestinal epithelial cells usually undergo apoptosis in culture after sodium butyrate treatment (6, 21, 24) . RIE cells that are genetically engineered to overexpress COX-2 have two interesting phenotypic changes: 1) they do not undergo apoptosis in response to sodium butyrate treatment as the normal cells do, and 2) they have increased adhesion to extracellular matrix proteins compared with normal or antisense cells. These two properties certainly may be considered important in tumorigenesis (71). Additional experiments are underway to determine the molecular basis for these phenotvpic changes involving increased adhesion to extracellular matrix and inhibition of apoptosis. COX-1(-/-) females mated to COX-1(-/-) males produce few live offspring, which is probably due to parturition difficulties in the COXl( -/-) female. Several distinct phenotypic changes were observed in the COX-2 null mice: 1) absence of corpora lutea in the developing ovary by one group (lo), 2) renal nephropathy (10,44), 3) cardiac fibrosis by one group (lo), and 4) increased susceptibility to peritonitis by another group (44). Clearly, these results implicate the importance of COX-2 activity in the development of diverse organ systems.
S-Y
The purpose of this brief review is to stimulate more consideration of the biological role of these enzymes and to provide an update on the most recent studies regarding their characterization. COX-1 and COX-2 are key enzymes in the production of a variety of eicosanoid products. These eicosanoids mediate numerous cellular responses, including modulation of cellular adhesion, differentiation, and mitogenesis. 40.
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